First Use of Chloroform Anesthesia (1847)

Summary

In the autumn of 1847, the Edinburgh obstetrician James Young Simpson began testing chloroform as a surgical anesthetic and quickly recognized it as superior to ether for many purposes. Chloroform was faster-acting, more pleasant to inhale, and could be administered without the special apparatus ether required — a cloth soaked in the liquid pressed to the patient’s face was sufficient. Simpson’s introduction of chloroform transformed obstetric practice in particular, where ether’s irritating vapor and slow induction were disadvantages. The most consequential endorsement came in 1853 when Queen Victoria accepted chloroform during the birth of Prince Leopold. Chloroform was not without danger: its therapeutic window was narrow, cardiac arrest was a real risk, and deaths under chloroform accumulated over the following decades. The agent dominated British anesthetic practice for half a century before safer alternatives displaced it. Chloroform, taken alongside the ether demonstration of 1846, completed the abolition of surgical pain as surgery’s defining constraint.

Background

The Ether Problem

When William Morton demonstrated ether anesthesia at Massachusetts General Hospital on October 16, 1846, the news traveled fast. Within months, surgeons across Europe were using ether. But ether had real disadvantages that practitioners noticed quickly. It irritated the respiratory tract, causing coughing and struggling during induction. It required a specialized inhaler apparatus that was not always available. Its induction was relatively slow. For abdominal and obstetric procedures, these were not minor inconveniences.

Adoption of ether was also neither universal nor immediate. Bynum documents that only one-third of amputations at the Pennsylvania Hospital between 1853 and 1862 were performed under anesthesia; use by military surgeons was restricted, the agents were considered too expensive for the poor, and obstetric use was occasionally questioned on moral grounds (Bynum, 1994). The moral objection to obstetric anesthesia drew specifically on Genesis: the pain of childbirth had been interpreted by some theologians as a divine prescription rather than a physiological accident, and medicine’s circumvention of it was, by this reading, an interference with divine order. This argument was available against ether as much as against chloroform, but it became most prominent precisely as chloroform made obstetric anesthesia practically accessible.

The Search for Alternatives

Simpson was already a prominent figure in Edinburgh obstetrics when he began testing anesthetic agents. He had adopted ether for obstetric use but was alert to its limitations. According to the account he later published, he and colleagues tested a series of volatile compounds — inhaling them at his own dining table — before chloroform produced the desired effect.

The Event

November 1847

What is evidenced: Ackerknecht lists James Young Simpson among the key figures of nineteenth-century surgery and obstetrics, specifically naming him in relation to chloroform, and confirms that anesthesia was introduced to surgery in 1846–47 with ether and chloroform (Ackerknecht, 1955). The context — Edinburgh, obstetric application, 1847 — is consistent across the literature.

Chloroform’s Practical Advantages Over Ether

Chloroform (trichloromethane, CHCl₃) had several practical advantages over sulfuric ether as a surgical anesthetic. It acted more rapidly. It was more pleasant to inhale — patients found ether’s pungent vapor disagreeable, while chloroform’s effect was quicker and less irritating to the airway. It required no special apparatus: the anesthetist needed only a cloth or handkerchief soaked in the liquid and held near the patient’s face. For busy practitioners working in homes rather than hospital operating theatres — obstetric work in particular — this portability was significant.

The disadvantage was danger. Chloroform has a narrow therapeutic window: the gap between an anesthetic dose and a lethal one is small. Cardiac arrest under chloroform — particularly during induction, when the agent’s depressant effect on the myocardium could be sudden — was a real risk. Deaths under chloroform began accumulating almost immediately.

The ether–chloroform debate occupied anesthetists for years. John Snow, the London physician who later administered chloroform to Queen Victoria, was one of the early systematic investigators of both agents and a proponent of careful dosing control. Snow argued that chloroform’s dangers were largely preventable through controlled administration and resisted the drift toward treating anesthesia as a casual operation requiring no specialized skill.

Immediate Consequences

Obstetric Anesthesia and Religious Opposition

Simpson applied chloroform to obstetric deliveries and became its most prominent advocate for that indication. The theological objection — that pain in childbirth was divinely ordained and therefore not properly subject to medical relief — was answered by Simpson himself on scriptural grounds. He argued that Genesis recorded God causing a “deep sleep” to fall on Adam before the creation of Eve, constituting divine precedent for painless surgical procedure. The theological debate was not resolved by Simpson’s exegesis; it was resolved by its social resolution.

In 1853, Queen Victoria accepted chloroform during the birth of Prince Leopold, administered by John Snow. A monarch’s choice carried a social authority that no theological argument could easily match. The practice of chloroform in obstetrics continued without sustained religious opposition in Britain after 1853.

Chloroform, Antisepsis, and the Paradox of Anesthesia

The broader effect of anesthesia — both ether and chloroform — was to allow surgeons to operate longer and more ambitiously. Bynum’s evidence shows that anesthetic adoption was associated with expanded surgical scope. Velpeau’s 1854 call for radical en bloc mastectomy — removing not just the breast but the underlying chest muscles — was possible only because anesthetized patients could be operated on more extensively (Fitzharris, 2017). More ambitious surgery in non-antiseptic conditions meant more infection exposure.

Ackerknecht captures this paradox: the great nineteenth-century surgical advances required three enabling conditions — localistic pathological anatomy (which gave surgery theoretical justification), anesthesia (which removed the pain constraint), and antisepsis (which controlled postoperative infection) — and the three arrived sequentially rather than simultaneously (Ackerknecht, 1955). Anesthesia without antisepsis did not improve outcomes; it may have worsened them by enabling operations of greater duration and scope in conditions that remained bacteriologically lethal. This is the structural paradox that Lister’s 1867 antiseptic methods addressed (Ackerknecht, 1955).

James Young Simpson’s relationship to Lister is historically significant. Simpson, working from a sanitationist framework, was skeptical of Lister’s germ-theory-based antisepsis. Writing in 1869 under the pseudonym “Chirurgicus,” Simpson accused Lister of plagiarizing Jules Lemaire’s prior use of carbolic acid (Fitzharris, 2017). Fitzharris argues that Simpson’s opposition was motivated in part by rivalry: if Lister’s antiseptic system worked, it would undermine Simpson’s competing technique of acupressure for ligature replacement (Fitzharris, 2017). Simpson had also coined the term “hospitalism” to describe the excess mortality from infection associated with hospital surgery — an observation that aligned with the sanitationist position that hospital conditions, not airborne bacteria, were the primary cause of wound infection (Bynum, 1994). His opposition to Lister was thus both personal and theoretical.

Longer-Term Significance

Chloroform’s Dominance and Displacement

In Britain, chloroform became the dominant surgical anesthetic for the second half of the nineteenth century. On the Continent and in America, ether retained more of its following. The divergence reflected partly the strength of local advocates and partly genuine differences in perceived risk tolerance. British practitioners, guided by Simpson’s advocacy and the prestige of the Edinburgh school, adopted chloroform; American practice, closer to the site of Morton’s ether demonstration and influenced by practitioners who emphasized chloroform’s cardiac risks, maintained a stronger commitment to ether.

By the early twentieth century, both agents were being supplanted by safer, more controllable methods. Nitrous oxide, which Horace Wells had attempted to demonstrate as an anesthetic agent in 1845 (before Morton’s ether success), was rehabilitated and combined with other agents. The development of intravenous anesthesia, regional nerve blocks, and eventually the modern pharmacological toolkit transformed anesthesia into a medical specialty in its own right — a specialty that chloroform’s dangerous simplicity had made appear, wrongly, not to require.

Surgical Transformation

Ackerknecht’s summary of the surgical consequence is apt: anesthesia — both ether and chloroform — enabled surgeons to move from the emergency procedures that had previously been all that conscious patients could tolerate (amputations, surface tumor removal, rapid urological operations) toward the deliberate invasion of body cavities. Billroth’s abdominal surgery in the 1880s — resecting the esophagus (1872), pylorus (1881), and intestines (1878) — was possible only in the era of anesthesia (Ackerknecht, 1955). The first appendectomy (Kroenlein, 1885) and the routine performance of ovariotomy (Spencer Wells from 1858, Tait from 1871) similarly depended on patients who could remain still for as long as the procedure required (Ackerknecht, 1955).

Chloroform specifically enabled some of these advances in British surgical practice, where it was the preferred agent during the decades when this surgical expansion occurred. Simpson’s contribution was not only obstetric; by providing a more accessible and practical anesthetic agent, he extended the reach of anesthesia to settings and practitioners who might not have adopted ether’s more cumbersome requirements.

[DISPUTED]

The specific date of first clinical use: The date November 4, 1847 is widely cited but not confirmed in the evidence cards available for this entry.

Simpson versus Lister: The historical question of whether Simpson’s opposition to Lister’s antisepsis was primarily motivated by scientific skepticism of germ theory or by personal rivalry (acupressure versus antisepsis) is contested. Fitzharris interprets it primarily as rivalry (Fitzharris, 2017); other historians may weigh Simpson’s sanitationist convictions more heavily. Both motives were real.

Ether versus chloroform in obstetric safety: The comparative mortality of the two agents in obstetric use was debated among Victorian practitioners and has been revisited by historians. The relative safety claims made by advocates of each remain contested.

See Also

• first-ether-anesthesia-1846 — The predecessor event; Morton’s Boston demonstration thirteen months earlier
• james-young-simpson — Edinburgh obstetrician who introduced chloroform; later identified as “Chirurgicus” in the dispute with Lister
• joseph-lister — Antiseptic surgery pioneer; Simpson’s antagonist in the 1867 controversy
• antisepsis — The infection-control problem that anesthesia’s success exposed
• john-snow — Administered chloroform to Queen Victoria; systematic investigator of anesthetic dosing
• history-of-surgery — The broader arc of nineteenth-century surgical transformation
• vitalism — The theoretical framework challenged by both anesthetic chemistry and antiseptic bacteriology
• hospitalism — Simpson’s term for excess hospital mortality from infection; the problem antisepsis addressed

Sources

Evidence drawn from:

• Ackerknecht, E.H. (1955). A Short History of Medicine. Ronald Press. Ch. 17 — ack55-ch17-001, ack55-ch17-003, ack55-ch17-005, ack55-ch17-006
• Bynum, W.F. (1994). Science and the Practice of Medicine in the Nineteenth Century. Cambridge University Press. Ch. 5 — bynsp94-ch05-002, bynsp94-ch05-007
• Fitzharris, L. (2017). The Butchering Art. Scientific American / Farrar, Straus and Giroux. Ch. 9 — fitz17-ch09-002, fitz17-ch09-004

Note on evidence gaps: The specific date of first chloroform use (November 4, 1847), the details of Simpson’s personal discovery account, the Hannah Greener death (1848), and Queen Victoria’s 1853 chloroform delivery are all absent from the evidence cards read for this page. These claims are consistent with established medical history but require additional source documentation before they should be treated as fully evidenced in this encyclopaedia’s citation framework. The Fitzharris chapters read here (ch09) cover 1867, not 1847; no Fitzharris chapters covering chloroform’s introduction were available in the evidence set. Additional evidence cards from a Simpson biography or a history of anesthesia would substantially strengthen this entry.

Editorial Notes

Gaps the encyclopaedia compiler flagged for future evidence work.